The most differentially over-represented signaling pathways in LUAD patients with the elevated MND1 expression included the p53 signaling pathway, pancreatic cancer, small cell lung cancer, bladder cancer, melanoma, and colorectal cancer (Table 5). This evidence concerns the gene MND1 and small cell lung carcinoma.